| Subjects |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Management > Business Innovation - Ignoring Content |
|
Subjects - Business Innovation - Ignoring Content
Creativity can be defined as problem identification and idea generation whilst innovation can be defined as i According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product dea selection, development and commercialisation. There are other useful definitions in this field, for exam ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in ple, creativity can be defined as consisting of a number of ideas, a number of diverse ideas and a number of lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. novel ideas. There are distinct processes that enhance problem identification and idea generation and, simil here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe arly, distinct processes that enhance idea selection, development and commercialisation. Whilst there is no s d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro re fire route to commercial success, these processes improve the probability that good ideas will be generate ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc d and selected and that investment in developing and commercialising those ideas will not be wasted. Ign easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi oring Content A useful approach when generating ideas is simply to ignore content. Evaluating content i nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically s a hindrance rather than an enhancer. If the people who wrote Red Riding Hood had realised the number of int and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ erpretations and analysis it was going to receive, they may have given up on the project. Ignoring content a ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi lows a number of processes to occur, including: a) Isolates creative from critical thinking. The two should ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a be separate and distinct. Writing and rewriting are two different processes. Critical thinking is best done dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod in the presence of and utilising the competencies of other people. b) Allows disparate, novel, diverse, nons cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin ensical, non-related and irrelevant ideas to thrive. The basis of lateral thinking. c) Helps to abandon defe tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen nces, reveal the innermost self, treat all ideas as ‘normal,’ reduces evaluation apprehension etc. These and t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel other topics are covered in depth in the MBA dissertation on Managing Creativity & Innovation, which can be p ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust urchased (along with a Creativity and Innovation DIY Audit, Good Idea Generator Software and Power Point Pres y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products entation) from http://www.managing-creativity.com . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de / You can also receive a regular, free newsletter by entering your email address at this site. You are elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip free to reproduce this article as long as no changes are made and the author's name and site URL are retained tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:IT & ERP Consulting: Industry Trends Business Coaching #2 - Work-Life Balance & Fulfilled Living
|